Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Protein that regulates aging may provide key to new diabetes therapies

18.08.2005


Opening the possibility of new therapies for type 2 diabetes, researchers at Washington University School of Medicine in St. Louis have found that a protein called Sirt1 enhances the secretion of insulin in mice and allows them to better control blood glucose levels. Their study will appear in the August 17 issue of Cell Metabolism.



According to senior author Shin-ichiro Imai, M.D., the finding suggests that therapies that increase the activity of Sirt1 could be of benefit in type 2 diabetes. "We are especially interested in how we can activate Sirt1 in a natural way," says Imai, assistant professor of molecular biology and pharmacology. "One option we are investigating is increasing the body’s synthesis of NAD, a necessary cofactor for Sirt1’s function. Because Vitamin B3, often called niacin, is a building block of NAD, it has interesting potential."

Sirt1 is referred to as Sir2 in lower organisms where it has previously proven to be a key to aging and longevity: Increasing the amount of Sir2 dramatically extends life spans in experimental yeast, worms and flies.


"Researchers, such as myself, who study aging are enthusiastically investigating Sir2," Imai says. "In 2000, I found that Sir2 responds to the level of energy in the form of NAD available in cells. Further research has shown that Sir2 connects nutrient status and longevity."

In mammals, scientists have shown that restricting calories can extend life span and also leads to an increase in Sirt1, the mammalian version of Sir2. Sirt1 reacts to changes in nutrient availability in a wide variety of tissues.

Uptake of the basic nutrient glucose is controlled by insulin, and Imai’s research group found that the cells responsible for secreting insulin--Beta cells in the pancreas--also produce Sirt1. So they investigated the effects of increasing the amount of Sirt1 in pancreatic Beta cells in mice to better understand the link between Sirt1 and glucose metabolism.

They designed transgenic mice with a genetic switch that turned up the gene that makes Sirt1 in Beta cells. "We confirmed that the mice overexpress Sirt1 proteins specifically in pancreatic Beta cells, not in other kinds of pancreatic cells, and not in brain, liver, kidney, fat or muscle," says Kathryn Moynihan, graduate research assistant.

Compared to wild-type mice, the transgenic mice had the same levels of blood glucose and insulin both when well-fed and during fasting. They were of similar weights and their pancreatic cells looked very similar in size and structure.

But when the two sets of mice were given a large dose of glucose, a difference became apparent. The transgenic mice produced more insulin and cleared glucose from their blood streams significantly faster than did wild-type mice.

Challenging the mice’s systems with glucose in this manner mimics the glucose tolerance tests used to check for diabetes in human patients. Diabetic patients clear glucose more slowly than do non-diabetics in these tests.

"If your system reacted like that of these transgenic mice, you could process sugar more quickly and much more efficiently after eating sweets," Imai says.

The research group found that the transgenic mice retained their unique Beta cell function as they aged from three months to eight months, the equivalent of middle age in humans. The researchers are continuing to track the progress of the mice, which are now about 20 months old.

An analysis of the activity of genes in the Beta cells showed that several genes linked to insulin secretion were affected by the increased expression of Sirt1. Most prominently, Sirt1 turned down the activity of a gene that decreases insulin secretion.

"The gene makes uncoupling protein 2, which is intimately connected to ATP production," Imai says. "ATP is a fundamental source of energy for metabolism, and by downregulating uncoupling protein 2, Sirt1 not only enhances insulin secretion, but increases ATP energy. This is a further indication of the connection between Sirt1 and energy status."

Imai feels that Sirt1 is probably a very important regulator that integrates cellular response to different types of nutrients, such as glucose, amino acids, and fatty acids. Continued research in the lab will use the transgenic mice to further investigate Sirt1’s role in this response.

Gwen Ericson | EurekAlert!
Further information:
http://www.wustl.edu

More articles from Life Sciences:

nachricht Newly designed molecule binds nitrogen
23.02.2018 | Julius-Maximilians-Universität Würzburg

nachricht Atomic Design by Water
23.02.2018 | Max-Planck-Institut für Eisenforschung GmbH

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Attoseconds break into atomic interior

A newly developed laser technology has enabled physicists in the Laboratory for Attosecond Physics (jointly run by LMU Munich and the Max Planck Institute of Quantum Optics) to generate attosecond bursts of high-energy photons of unprecedented intensity. This has made it possible to observe the interaction of multiple photons in a single such pulse with electrons in the inner orbital shell of an atom.

In order to observe the ultrafast electron motion in the inner shells of atoms with short light pulses, the pulses must not only be ultrashort, but very...

Im Focus: Good vibrations feel the force

A group of researchers led by Andrea Cavalleri at the Max Planck Institute for Structure and Dynamics of Matter (MPSD) in Hamburg has demonstrated a new method enabling precise measurements of the interatomic forces that hold crystalline solids together. The paper Probing the Interatomic Potential of Solids by Strong-Field Nonlinear Phononics, published online in Nature, explains how a terahertz-frequency laser pulse can drive very large deformations of the crystal.

By measuring the highly unusual atomic trajectories under extreme electromagnetic transients, the MPSD group could reconstruct how rigid the atomic bonds are...

Im Focus: Developing reliable quantum computers

International research team makes important step on the path to solving certification problems

Quantum computers may one day solve algorithmic problems which even the biggest supercomputers today can’t manage. But how do you test a quantum computer to...

Im Focus: In best circles: First integrated circuit from self-assembled polymer

For the first time, a team of researchers at the Max-Planck Institute (MPI) for Polymer Research in Mainz, Germany, has succeeded in making an integrated circuit (IC) from just a monolayer of a semiconducting polymer via a bottom-up, self-assembly approach.

In the self-assembly process, the semiconducting polymer arranges itself into an ordered monolayer in a transistor. The transistors are binary switches used...

Im Focus: Demonstration of a single molecule piezoelectric effect

Breakthrough provides a new concept of the design of molecular motors, sensors and electricity generators at nanoscale

Researchers from the Institute of Organic Chemistry and Biochemistry of the CAS (IOCB Prague), Institute of Physics of the CAS (IP CAS) and Palacký University...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

VideoLinks
Industry & Economy
Event News

2nd International Conference on High Temperature Shape Memory Alloys (HTSMAs)

15.02.2018 | Event News

Aachen DC Grid Summit 2018

13.02.2018 | Event News

How Global Climate Policy Can Learn from the Energy Transition

12.02.2018 | Event News

 
Latest News

Basque researchers turn light upside down

23.02.2018 | Physics and Astronomy

Finnish research group discovers a new immune system regulator

23.02.2018 | Health and Medicine

Attoseconds break into atomic interior

23.02.2018 | Physics and Astronomy

VideoLinks
Science & Research
Overview of more VideoLinks >>>